These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6795658)

  • 21. Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan.
    Székely JI; Sharpe LG; Jaffe JH
    Pharmacol Biochem Behav; 1991 Oct; 40(2):381-6. PubMed ID: 1805242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phencyclidine-induced stereotyped behaviors after injection of ethylketocyclazocine, Mr 2266 and naltrexone in rats.
    Nabeshima T; Hiramatsu M; Kameyama T
    Brain Res; 1986 Jul; 378(2):234-9. PubMed ID: 3015356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation of phencyclidine-induced dopamine-dependent behaviors in rats after pretreatments with serotonin-depletors.
    Yamaguchi K; Nabeshima T; Kameyama T
    J Pharmacobiodyn; 1986 May; 9(5):479-89. PubMed ID: 2945001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of caramiphen and phencyclidine alone and in combination on behavior in the rat.
    Székely JI; Sharpe LG; Katz JL
    Pharmacol Biochem Behav; 1994 Mar; 47(3):709-13. PubMed ID: 8208792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different effects of ethylketocyclazocine on phencyclidine- and N-allylnormetazocine-induced stereotyped behaviors in rats.
    Hiramatsu M; Nabeshima T; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1987 Dec; 28(4):489-94. PubMed ID: 2893389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine.
    Nabeshima T; Fukaya H; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    Eur J Pharmacol; 1987 Mar; 135(1):23-33. PubMed ID: 3569423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
    Quock RM; Lucas TS; Hartl TJ
    Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats.
    Abekawa T; Honda M; Ito K; Koyama T
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):247-56. PubMed ID: 12898123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioral effects of chronic phencyclidine administration in rats.
    Sturgeon RD; Fessler RG; London SF; Meltzer HY
    Psychopharmacology (Berl); 1982; 76(1):52-6. PubMed ID: 6805009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors.
    French ED; Jacobson AE; Rice KC
    Eur J Pharmacol; 1987 Aug; 140(3):267-74. PubMed ID: 2820762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats.
    Fessler RG; Sturgeon RD; Meltzer HY
    Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anticonvulsant and behavioral effects of phencyclidine and ketamine following chronic treatment in rats.
    Leccese AP; Marquis KL; Mattia A; Moreton JE
    Behav Brain Res; 1986 Dec; 22(3):257-64. PubMed ID: 3790247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of apomorphine and haldol on PCP induced behavioral and motor abnormalities in the rat.
    Garey RE; McQuitty S; Tootle D; Heath RG
    Life Sci; 1980 Jan; 26(4):277-84. PubMed ID: 7188782
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of opiates with dopamine receptors: receptor binding and behavioral assays.
    Carlson KR; Seeger TF
    Pharmacol Biochem Behav; 1982 Jan; 16(1):119-24. PubMed ID: 6173883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naloxone does not antagonize PCP-induced stimulation of the pituitary-adrenal axis in the rat.
    Pechnick RN; George R; Poland RE
    Life Sci; 1989; 44(2):143-7. PubMed ID: 2536875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circling behavior induced by phencyclidine in mice and its inhibition by naloxone.
    Eshel Y; Korczyn AM
    Experientia; 1985 Jan; 41(1):73-4. PubMed ID: 3967742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scopolamine produces locomotor stereotypy in an open field but apomorphine does not.
    Mueller K; Peel JL
    Pharmacol Biochem Behav; 1990 Jul; 36(3):613-7. PubMed ID: 2377661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice.
    Hitri A; O'Connor DA; Cohen JM; Keuler DJ; Deutsch SI
    Clin Neuropharmacol; 1993 Jun; 16(3):220-36. PubMed ID: 8504439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period.
    Haggerty GC; Forney RB; Johnson JM
    Toxicol Appl Pharmacol; 1984 Sep; 75(3):444-53. PubMed ID: 6540902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.